You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 263 No. 4, January 26, 1990 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Council Report
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Medical Applications of Fetal Tissue Transplantation

Council on Scientific Affairs and Council on Ethical and Judicial Affairs

JAMA. 1990;263(4):565-570.


Abstract

Fetal tissue transplantation has been attempted for a limited number of clinical disorders, including Parkinson's disease, diabetes, immunodeficiency disorders, and several metabolic disorders. Fetal tissue has intrinsic properties— ability to differentiate into multiple cell types, growth and proliferative ability, growth factor production, and reduced antigenicity—that make it attractive for transplantation research. At this time the results from fetal tissue grafts for Parkinson's disease and diabetes have not demonstrated significant long-term clinical benefit to patients with these disorders. Further research will be necessary to determine the potential value of fetal tissue transplantation. For these clinical investigations to proceed, specific ethical guidelines are needed to ensure that fetal tissue derived from elective abortions is used in a morally acceptable manner. These guidelines should separate, to the greatest extent possible, the decision by a woman to have an abortion from her consent to donate the postmortem tissue for transplantation purposes. Such ethical guidelines are offered in this report.

(JAMA. 1990;263:565-570)



Author Affiliations

From the Council on Scientific Affairs and the Council on Ethical and Judicial Affairs, American Medical Association, Chicago, III.


Footnotes

This report was submitted to the House of Delegates of the American Medical Association at the June 1989 Annual Meeting as a policy report of the Council on Scientific Affairs and the Council on Ethical and Judicial Affairs.

This report is not intended to be construed or to serve as a standard of medical care. Standards of medical care are determined on the basis of all of the facts and circumstances involved in an individual case and are subject to change as scientific knowledge and technology advance and patterns of practice evolve. This report reflects the views of scientific literature as of June 1989.

Reprint requests to the Council on Scientific Affairs, American Medical Association, 535 N Dearborn St, Chicago, IL 60610 (William R. Hendee, PhD).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

JAMA, Abortion, and Editorial Responsibility
Lundberg
JAMA 1998;280:740-740.
FULL TEXT  

At the Margins of Humanity: Fetal Positions in Science and Medicine
Casper
Science Technology Human Values 1994;19:307-323.
ABSTRACT  

Physician Attitudes toward the Regulation of Fetal Tissue Therapies: Empirical Findings and Implications for Public Policy
Mullen and Lowy
J Law Med Ethics 1993;21:241-250.
 

Neurology
Joynt
JAMA 1990;263:2660-2661.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.